This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Christiane Reute: Innovator in Pharmaceutical Chemistry
Introduction
Christiane Reute is an accomplished inventor based in Leverkusen, Germany, known for her contributions to pharmaceutical chemistry. With a focus on innovative compounds, Reute has made significant strides in the field, culminating in a notable patent that addresses important medical applications.
Latest Patents
Reute holds a patent for a co-crystal compound of rivaroxaban and malonic acid. This invention relates to a novel cocrystal compound of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide (rivaroxaban) and malonic acid. The patent includes processes for its preparation, the medicaments comprising this compound, and their use in controlling diseases.
Career Highlights
Christiane Reute is a dedicated professional at Bayer Intellectual Property GmbH. Her work focuses on developing advanced pharmaceutical compounds that can revolutionize how certain diseases are treated. Through her innovative research and dedication, she has successfully contributed to Bayer's portfolio of medical solutions.
Collaborations
Throughout her career, Reute has collaborated with esteemed colleagues, including Alfons Grunenberg and Karsten Fähnrich. Their collective expertise and teamwork have played a pivotal role in the successful development of groundbreaking inventions within their field.
Conclusion
Christiane Reute exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents not only enhance the scientific community but also pave the way for new treatment options in medicine. Her ongoing work continues to inspire future inventors and highlights the importance of collaborative efforts in achieving great advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
